Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (8): 762-767.doi: 10.19982/j.issn.1000-6621.20220207
• Interpretation of Standards • Previous Articles Next Articles
Received:
2022-06-02
Online:
2022-08-10
Published:
2022-08-03
Contact:
Cheng Jun
E-mail:chengjun@chinacdc.cn
CLC Number:
Cheng Jun, Lu Wei. Interpretation of Guideline on tuberculosis infection prevention and control in primary health care institute[J]. Chinese Journal of Antituberculosis, 2022, 44(8): 762-767. doi: 10.19982/j.issn.1000-6621.20220207
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220207
[1] | World Health Organization. The End TB strategy. Geneva: World Health Organization, 2015. |
[2] |
Vigenschow A, Adegbite BR, Edoa JR, et al. Tuberculosis infection control measures in healthcare facilities in Moyen-Ogooué Province, Gabon. BMC Health Serv Res, 2021, 21(1):1200. doi: 10.1186/s12913-021-07236-z.
doi: 10.1186/s12913-021-07236-z pmid: 34740361 |
[3] |
Schepisi MS, Sotgiu G, Contini S, et al. Tuberculosis transmission from healthcare workers to patients and co-workers a systematic literature review and meta-analysis. PLoS One, 2015, 10(4):e0121639. doi: 10.1371/journal.pone.0121639.
doi: 10.1371/journal.pone.0121639 |
[4] |
Uden L, Barber E, Ford N, et al. Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-Analysis. Open Forum Infect Dis, 2017, 4(3):ofx137. doi: 10.1093/ofid/ofx137.
doi: 10.1093/ofid/ofx137 URL |
[5] | 王黎霞, 成诗明, 何广学, 等. 中国结核感染预防控制手册. 北京: 中国协和医科大学出版社, 2010:7. |
[6] | 王黎霞, 成诗明, 何广学, 等. 中国结核感染控制标准操作程序. 北京: 人民卫生出版社, 2012:10. |
[7] | World Health Organization. WHO guidelines on tuberculosis prevention and control 2019 update. Geneva: World Health Organization, 2019. |
[8] | World Health Organization. 世界卫生组织结核感染预防控制指南(2019年更新版). 成君,张慧, 译. 北京: 人民卫生出版社, 2020:9. |
[9] | 耿梦杰, 宋渝丹, 赵飞, 等. 国内外医务人员结核感染控制现状的比较研究. 中国防痨杂志, 2013, 35(8):581-586. |
[10] |
张炜敏, 何广学, 洪峰. 医疗卫生机构医务人员结核病感染控制现状. 中国感染控制杂志, 2011, 10(4):248-251. doi: 10.3969/j.issn.1671-9638.2011.04.003.
doi: 10.3969/j.issn.1671-9638.2011.04.003 |
[11] |
Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in rural China: baseline results of a population-based,multicenter,prospective cohort study. Lancet Infect Dis, 2015, 15(3): 310-319. doi: 10.1016/S1473-3099(14)71085-0.
doi: 10.1016/S1473-3099(14)71085-0 URL |
[12] | 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012, 34(8):485-508. |
[13] |
王前, 李涛, 杜昕, 等. 2015—2019年全国肺结核报告发病情况分析. 中国防痨杂志, 2021, 43(2): 107-112. doi: 10.3969/j.issn.1000-6621.2021.02.002.
doi: 10.3969/j.issn.1000-6621.2021.02.002 |
[14] |
He G, Li Y, Zhao F, et al. The prevalence and incidence of latent tuberculosis infection and its associated factors among village doctors in China. PLoS One, 2015, 10 (5): e0124097. doi: 10.1371/journal.pone.0124097.
doi: 10.1371/journal.pone.0124097 |
[15] |
Tadesse AW, Alagaw A, Kassa M, et al. Tuberculosis infection control practices and associated factors among healthcare workers in hospitals of GamoGofa Zone, Southern Ethiopia, institution-based cross-sectional study. PLoS One, 2020, 15(9):e0239159. doi: 10.1371/journal.pone.0239159.
doi: 10.1371/journal.pone.0239159 |
[16] |
Zhao F, Cheng J, Cheng SM, et al. The Current Status and Challenges Regarding Tuberculosis Infection Control in Health Care Facilities in China. Biomed Environ Sci, 2015, 28(11):848-854. doi: 10.3967/bes2015.118.
doi: 10.3967/bes2015.118 pmid: 26695365 |
[17] | 陈琴南. 农村基层医疗机构医院感染管理现状及改进措施. 中华医院感染学杂志, 2010, 20 (14): 2088-2089. |
[18] |
胡冬梅, 孟庆琳, 宋渝丹, 等. 内蒙古自治区乡村医生结核感染控制知识知晓现状及影响因素分析. 中国防痨杂志, 2015, 37 (12): 1187-1191. doi: 10.3969/j.issn.1000-6621.2015.12.002.
doi: 10.3969/j.issn.1000-6621.2015.12.002 |
[19] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发全国结核病防治规划(2011—2015年)的通知. 国办发〔2011〕53号. 2011-11-17. |
[20] | 中华人民共和国卫生部. 结核病防治管理办法. 卫生部令第92号. 2013-02-20. |
[21] | 中华人民共和国国家卫生和计划生育委员会办公厅. 国家卫生计生委办公厅关于印发结核病患者健康管理服务规范的通知. 国卫办基层函〔2015〕880号. 2015-10-15. |
[22] | 中华人民共和国国务院办公厅. 国务院办公厅关于关于推进分级诊疗制度建设的指导意见. 国办发〔2015〕70号. 2015-09-11. |
[23] | 中华人民共和国国家统计局. 中国统计年鉴-2019.北京: 中国统计出版社有限公司, 2019. |
[24] | 中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02. |
[25] | 赵雁林, 陈明亭. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021: 5. |
[26] | 中华人民共和国国家统计局. 中华人民共和国2019年国民经济和社会发展统计公报. 2020-02-28. |
[27] | 中华人民共和国国家卫生健康委员会. 2019年我国卫生健康事业发展统计公报. 2020-06-06. |
[28] | 中华人民共和国国家卫生和计划生育委员会办公厅. 国家卫生计生委办公厅关于印发基层医疗机构医院感染管理基本要求的通知. 国卫办医发〔2013〕40号. 2013-12-23. |
[29] | World Health Organization. Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings, 1999. Geneva: World Health Organization, 1999. |
[30] | World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. Geneva: World Health Organization, 2016. |
[31] | 中华人民共和国国家卫生和计划生育委员会. WS/T 511—2016 经空气传播疾病医院感染预防与控制规范. 2016-12-27. |
[32] | 中华人民共和国国家卫生健康委员会. WS/T 591—2018 医疗机构门急诊医院感染管理规范. 2018-05-10. |
[33] |
Claassens MM, van Schalkwyk C, du Toit E, et al. Tuberculosis in healthcare workers and infection control measures at primary healthcare facilities in South Africa. PLoS One, 2013, 8(10):e76272. doi: 10.1371/journal.pone.0076272.
doi: 10.1371/journal.pone.0076272 URL |
[34] |
Jacobson G, Hoyt DD, Bogen E. Tuberculosis in hospital employees as affected by an admission chest x-ray screening program. Dis Chest, 1957, 32(1):27-38. doi: 10.1378/chest.32.1.27.
doi: 10.1378/chest.32.1.27 |
[35] | 中华人民共和国卫生部. 医疗机构传染病预检分诊管理办法. 卫生部令第41号. 2005-02-28. |
[36] | 中华人民共和国传染病防治法. 主席令第十七号. 2004-08-28. |
[37] |
Menzies D, Fanning A, Yuan L, et al. Factors associated with tuberculin conversion in Canadian microbiology and pathology workers. Am J Respir Crit Care Med, 2003, 167(4): 599-602. doi: 10.1164/rccm.200208-873BC.
doi: 10.1164/rccm.200208-873BC URL |
[38] |
Fella P, Rivera P, Hale M, et al. Dramatic decrease in tuberculin skin test conversion rate among employees at a hospital in New York City. Am J Infect Control, 1995,23(6):352-356. doi: 10.1016/0196-6553(95)90265-1.
doi: 10.1016/0196-6553(95)90265-1 |
[39] |
Welbel SF, French AL, Bush P, et al. Protecting health care workers from tuberculosis: a 10-year experience. Am J Infect Control, 2009, 37(8): 668-673. doi: 10.1016/j.ajic.2009.01.004.
doi: 10.1016/j.ajic.2009.01.004 URL |
[40] | 中华人民共和国卫生部. 卫生部关于印发《消毒技术规范》(2002年版)的通知. 卫法监发〔2002〕282号. 2002-11-15. |
[41] | 国家市场监督管理总局, 国家标准化管理委员会. GB 27953—2020疫源地消毒剂通用要求. 2020-04-09. |
[42] |
Yanai H, Limpakarnjanarat K, Uthaivoravit W, et al. Risk of Mycobacterium tuberculosis infection and disease among health care workers, Chiang Rai, Thailand. Int J Tuberc Lung Dis, 2003, 7(1): 36-45.
pmid: 12701833 |
[43] | 中华人民共和国国家质量监督检验检疫总局, 中国国家标准化管理委员会. GB 19083—2010 医用防护口罩技术要求. 2010-09-02. |
[44] |
许婕, 王朝才, 夏愔愔, 等. 我国高疫情地区主动发现的肺结核患者干预前后接受治疗的意愿及影响因素分析. 中国防痨杂志, 2018, 40(10):1099-1109. doi: 10.3969/j.issn.1000-6621.2018.10.014.
doi: 10.3969/j.issn.1000-6621.2018.10.014 |
[45] | 于兰, 王静, 吕青, 等. 河南开封、重庆永川耐多药肺结核患者健康教育和健康促进服务效果评价. 中国健康教育, 2013, 29(4):365-366. |
[46] |
姜晓颖, 姜世闻, 高孟秋, 等. 活动性肺结核患者居家治疗感染控制的意见和建议. 中国防痨杂志, 2019, 41(9):920-925. doi: 10.3969/j.issn.1000-6621.2019.09.003.
doi: 10.3969/j.issn.1000-6621.2019.09.003 |
[47] |
李婕, 王黎霞, 成君, 等. 活动性肺结核患者家庭密切接触者结核病防治核心信息知晓情况调查. 中国防痨杂志, 2015, 37(10):1035-1041. doi: 10.3969/j.issn.1000-6621.2015.10.007.
doi: 10.3969/j.issn.1000-6621.2015.10.007 |
[48] | 中华人民共和国国家卫生健康委员会. WS/T 592—2018 医院感染预防与控制评价规范. 2018-05-10. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||